Profund Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$200K Buy
55,062
+10,140
+23% +$36.9K 0.01% 907
2025
Q1
$86.3K Buy
44,922
+7,252
+19% +$13.9K ﹤0.01% 963
2024
Q4
$71.6K Buy
+37,670
New +$71.6K ﹤0.01% 1089